Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

Abroad (travel likely)RecruitingPHASE2

Conditions

NonSegmental Vitiligo · Nonsegmental Vitiligo (Stable)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Contact: Study coordinator (Zhen J Peng, Phd) · Zhen-Peng@beijing-biotech.com · +86 13076790039

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

A Study of Zasocitinib in Adults With Nonsegmental Vitiligo

Nonsegmental Vitiligo

Abroad (travel likely)RecruitingPHASE2

Bryant, United States · Fountain Valley, United States

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

NonSegmental Vitiligo

Abroad (travel likely)RecruitingPHASE3

Buenos Aires, Argentina · Buenos Aires, Argentina

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo

Abroad (travel likely)RecruitingPHASE3

Birmingham, United States · Phoenix, United States

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

Non-segmental Vitiligo

Abroad (travel likely)RecruitingPHASE2

Huntington Beach, United States · Hollywood, United States